BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17805035)

  • 21. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
    Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
    Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ; Zacharin MR
    J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
    Hagino H; Nishizawa Y; Sone T; Morii H; Taketani Y; Nakamura T; Itabashi A; Mizunuma H; Ohashi Y; Shiraki M; Minamide T; Matsumoto T
    Bone; 2009 Jun; 44(6):1078-84. PubMed ID: 19264155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
    Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S
    Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral bisphosphonates improve Bone Mineral Density in adults with cystic fibrosis.
    Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Wen YC; Gibney J; Dodd JD; O'Shea D
    Ir Med J; 2005 Oct; 98(9):270-3. PubMed ID: 16300106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
    Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
    Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.
    Barr RD; Guo CY; Wiernikowski J; Webber C; Wright M; Atkinson S
    Med Pediatr Oncol; 2002 Jul; 39(1):44-6. PubMed ID: 12116079
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.
    Nomura S; Kurata Y; Tomiyama Y; Takubo T; Hasegawa M; Saigo K; Nishikawa M; Higasa S; Maeda Y; Hayashi K
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):622-7. PubMed ID: 19959489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy of alendronate in the prevention and treatment of postmenopausal osteoporosis].
    Cheng ZQ; Yin W; Fan JY; Ma TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):306-9. PubMed ID: 12905641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative osteopenia after treatment for acute lymphoblastic leukemia.
    Warner JT; Evans WD; Webb DK; Bell W; Gregory JW
    Pediatr Res; 1999 Apr; 45(4 Pt 1):544-51. PubMed ID: 10203147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.